Literature DB >> 300098

Tension reduction and alerting in man following chronic cerebellar stimulation for the relief of spasticity or intractable seizures.

M Riklan, T Cullinan, I S Cooper.   

Abstract

Neurologically impaired patients on therapeutic regimens of chronic cerebellar stimulation for periods ranging from 4 to 29 months (mean = 12.8 months) commonly reported amelioration of tension and/or anxiety. Cerebral palsy patients emphasized tension reduction while seizure patients primarily reported increased alertness. Increased alertness and improvement in speech and mood were also noted by many patients. These changes correlated significantly with symptom reduction and functional improvement. Although the mechanisms of these changes are not yet clear, psychological and neurological explanatory hypotheses were presented.

Entities:  

Mesh:

Year:  1977        PMID: 300098     DOI: 10.1097/00005053-197703000-00003

Source DB:  PubMed          Journal:  J Nerv Ment Dis        ISSN: 0022-3018            Impact factor:   2.254


  3 in total

1.  Abnormal brain functional connectivity leads to impaired mood and cognition in hyperthyroidism: a resting-state functional MRI study.

Authors:  Ling Li; Mengmeng Zhi; Zhenghua Hou; Yuqun Zhang; Yingying Yue; Yonggui Yuan
Journal:  Oncotarget       Date:  2017-01-24

Review 2.  Consensus Paper: Experimental Neurostimulation of the Cerebellum.

Authors:  Lauren N Miterko; Kenneth B Baker; Jaclyn Beckinghausen; Lynley V Bradnam; Michelle Y Cheng; Jessica Cooperrider; Mahlon R DeLong; Simona V Gornati; Mark Hallett; Detlef H Heck; Freek E Hoebeek; Abbas Z Kouzani; Sheng-Han Kuo; Elan D Louis; Andre Machado; Mario Manto; Alana B McCambridge; Michael A Nitsche; Nordeyn Oulad Ben Taib; Traian Popa; Masaki Tanaka; Dagmar Timmann; Gary K Steinberg; Eric H Wang; Thomas Wichmann; Tao Xie; Roy V Sillitoe
Journal:  Cerebellum       Date:  2019-12       Impact factor: 3.847

3.  Influence of cerebellar stereotactic stimulation on left-right electrodermal information transference in a patient with cerebral palsy.

Authors:  Petr Bob; Tomas Galanda; Peter Jombik; Jiri Raboch; Miroslav Galanda
Journal:  Neuropsychiatr Dis Treat       Date:  2013-11-29       Impact factor: 2.570

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.